Cargando…

An adult case of invasive pneumococcal disease due to serotype 12F-specific polysaccharide antibody failure following a 23-valent polysaccharide vaccination

A 68-year-old Japanese man was admitted to our hospital for an acute febrile illness with shivering and impaired consciousness. He was a previous smoker and had a history of chronic obstructive pulmonary disease, for which he inhaled steroid with a long-acting bronchodilator. He had received a 23-va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Yasuhiro, Yamamoto, Kazuko, Fukuda, Yuichi, Umemura, Asuka, Yoshida, Masataka, Ideguchi, Shuhei, Ashizawa, Nobuyuki, Hirayama, Tatsuro, Tashiro, Masato, Takazono, Takahiro, Imamura, Yoshifumi, Miyazaki, Taiga, Izumikawa, Koichi, Yanagihara, Katsunori, Chang, Bin, Mukae, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594767/ https://www.ncbi.nlm.nih.gov/pubmed/32990189 http://dx.doi.org/10.1080/22221751.2020.1830716

Ejemplares similares

ERG3-Encoding Sterol C5,6-DESATURASE in Candida albicans Is Required for Virulence in an Enterically Infected Invasive Candidiasis Mouse Model
por: Hirayama, Tatsuro, et al.
Publicado: (2020)

Correction to: Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report
por: Ito, Yuya, et al.
Publicado: (2021)

Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report
por: Ito, Yuya, et al.
Publicado: (2021)

Infectious Pneumonia and Lower Airway Microorganisms in Patients with Rheumatoid Arthritis
por: Ideguchi, Shuhei, et al.
Publicado: (2021)

Duration of antifungal therapy for septic pulmonary embolism caused by Candida albicans from a central venous catheter: A case report
por: Okuno, Daisuke, et al.
Publicado: (2020)

Serum Cytokines Usefulness for Understanding the Pathology in Allergic Bronchopulmonary Aspergillosis and Chronic Pulmonary Aspergillosis
por: Ito, Yuya, et al.
Publicado: (2022)

Autophagy-Inducing Factor Atg1 Is Required for Virulence in the Pathogenic Fungus Candida glabrata
por: Shimamura, Shintaro, et al.
Publicado: (2019)

Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
por: Tashiro, Masato, et al.
Publicado: (2017)

Human immunodeficiency virus-associated vacuolar encephalomyelopathy with granulomatous-lymphocytic interstitial lung disease improved after antiretroviral therapy: a case report
por: Akagi, Kazumasa, et al.
Publicado: (2020)

Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling
por: Irifune, Satoshi, et al.
Publicado: (2021)

Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation
por: Hirayama, Tatsuro, et al.
Publicado: (2020)

Roles of Elm1 in antifungal susceptibility and virulence in Candida glabrata
por: Ito, Yuya, et al.
Publicado: (2020)

Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata
por: Minematsu, Asuka, et al.
Publicado: (2019)

Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment
por: Takazono, Takahiro, et al.
Publicado: (2016)

Munchausen syndrome mimicking refractory subcutaneous abscess with bacteremia, diagnosed by repetitive element sequence-based polymerase chain reaction: a case report
por: Iwanaga, Naoki, et al.
Publicado: (2019)

Recurrent Streptococcus agalactiae Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-α Inhibitor
por: Yoshida, Masataka, et al.
Publicado: (2016)

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis
por: Ashizawa, Nobuyuki, et al.
Publicado: (2019)

Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests
por: Ashizawa, Nobuyuki, et al.
Publicado: (2021)

Severe Fever with Thrombocytopenia Syndrome Virus RNA in Semen, Japan
por: Koga, Satoru, et al.
Publicado: (2019)

Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly
por: Kuo, Chia-Sheng, et al.
Publicado: (2016)

Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report
por: Takazono, Takahiro, et al.
Publicado: (2014)

A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis
por: Tin Tin Htar , Myint, et al.
Publicado: (2013)

Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
por: Satomura, Kazunari, et al.
Publicado: (2014)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015)

A mortality prediction rule for non-elderly patients with community-acquired pneumonia
por: Tashiro, Masato, et al.
Publicado: (2016)

Novel and potent antimicrobial effects of caspofungin on drug-resistant Candida and bacteria
por: Sumiyoshi, Makoto, et al.
Publicado: (2020)

Detection of viral RNA in diverse body fluids in an SFTS patient with encephalopathy, gastrointestinal bleeding and pneumonia: a case report and literature review
por: Akagi, Kazumasa, et al.
Publicado: (2020)

Evaluation of a Novel FKS1 R1354H Mutation Associated with Caspofungin Resistance in Candida auris Using the CRISPR-Cas9 System
por: Kiyohara, Maiko, et al.
Publicado: (2023)

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
por: Migita, Kiyoshi, et al.
Publicado: (2015)

Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia
por: Haggenburg, Sabine, et al.
Publicado: (2023)

Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
por: Leach, Amanda J, et al.
Publicado: (2009)

Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults
por: Schmoele-Thoma, Beate, et al.
Publicado: (2019)

Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
por: Malene B, Mikkelsen, et al.
Publicado: (2023)

A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
por: Ngamprasertchai, Thundon, et al.
Publicado: (2023)

Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations
por: Wang, Yang, et al.
Publicado: (2017)

Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine
por: Whang, Yoon Hee, et al.
Publicado: (2020)

The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial
por: Izumi, Yasumori, et al.
Publicado: (2017)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017
por: Shimbashi, Reiko, et al.
Publicado: (2020)

The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain Complexes
por: Yamashita, Kohei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ustn7e1tsehlvitt7iunamsbta